Thinking and Memory Problems in People With HIV
NCT01875588 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1150
Last updated 2026-05-13
Summary
Background:
\- People with human immunodeficiency virus (HIV) can sometimes develop thinking and memory problems. These problems can vary widely, from few symptoms to severe problems with memory and concentration. It initially was thought that good HIV treatment could prevent almost all HIV-related memory problems. However, even people with low HIV viral loads can have these problems. It may be caused by HIV affecting the brain and spinal fluid. It is not yet clear why HIV causes these problems and why they may be worse in some people than others. Researchers want to study people with HIV and healthy volunteers to see how HIV may affect people with only small amounts of the virus in their blood.
Objectives:
\- To study thinking and memory problems in individuals with HIV that is otherwise controlled with medications.
Eligibility:
* Individuals between 18 of age or older whose HIV has been controlled with medications for at least 1 year.
* Healthy volunteers between 18 of age or older.
Design:
* Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. A neurological test will also be given. Participants will have a baseline imaging study of the brain.
* Within 12 weeks of the first visit, participants will have a second visit. Additional blood samples will be drawn. Another brain imaging study will be performed.
* Within 8 weeks of the second visit, participants will have a third visit to collect more blood samples. They will also provide spinal fluid samples, either as a single visit or a longer procedure.
* After this visit, participants will return every 12 months for up to 10 years. Blood samples will be collected as needed at these visits. Thinking and memory tests and imaging studies may also be given as needed. Spinal fluid may be collected at one visit a year.
Conditions
- HIV Positive
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Avindra Nath, M.D. · National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-08
- Primary Completion
- 2037-02-22
Countries
- United States
Study Locations
More Related Trials
-
Mild Neurocognitive Disorder in HIV Infection of the Brain
NCT01547754 ·Status: TERMINATED
-
Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1
NCT00476671 ·Status: COMPLETED
-
Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic
NCT02187796 ·Status: COMPLETED
-
HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs
NCT00001103 ·Status: COMPLETED
-
Assessment of Attentional Functioning in Children With HIV-1 Infection
NCT00001497 ·Status: COMPLETED
-
Functional Imaging Reserve in NeuroHIV
NCT03596268 ·Status: COMPLETED
-
Individualized Cognitive Training in HIV
NCT03122288 ·Status: COMPLETED ·Phase: NA
-
Mental Ability Challenge Study in Adults With and Without HIV
NCT03244488 ·Status: COMPLETED
-
Exploring Racial Disparities in Sleep Health and Neurocognitive Function
NCT04015830 ·Status: COMPLETED ·Phase: NA
-
Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study
NCT02592174 ·Status: COMPLETED ·Phase: NA
-
Men Who Have Sex With Men (MSM) Neurocog 1&2 Study
NCT01508559 ·Status: COMPLETED
-
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
NCT05586581 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of Decreased Mental Function Associated With HIV
NCT00027040 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Neuro-HAART in Patients With HIV
NCT01434654 ·Status: TERMINATED
-
The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort -
NCT01434563 ·Status: COMPLETED
-
Neural Correlates of Working Memory Training for HIV Patients
NCT02602418 ·Status: UNKNOWN ·Phase: NA
-
The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
NCT00002288 ·Status: COMPLETED ·Phase: NA
-
HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy
NCT04266002 ·Status: COMPLETED ·Phase: NA
-
Effect of Cenicriviroc on HIV Neurocognitive Impairment
NCT02128828 ·Status: COMPLETED ·Phase: PHASE2
-
Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials
NCT00000759 ·Status: COMPLETED
-
Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS
NCT02470351 ·Status: COMPLETED
-
Central Nervous System Disease in HIV-infected Children on HAART
NCT00110331 ·Status: COMPLETED
-
Effects of Glucocorticoids on Cognition in HIV-infected Women
NCT03237689 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Identification and Quantification of HIV CNS Latency Biomarkers
NCT02989285 ·Status: UNKNOWN
-
Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")
NCT01985399 ·Status: COMPLETED